M Etminan

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi request reprint Quantifying the interaction between angiotensin-converting enzyme inhibitors and aspirin: are we using the right method?
    M Etminan
    Department of Clinical Epidemiology, University of Toronto, Ontario, Canada
    Pharmacotherapy 21:1247-9. 2001
  2. ncbi request reprint Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials
    M Etminan
    Department of Pharmacy, Baycrest Center for Geriatric Care, Toronto, Ontario, Canada
    Drug Saf 24:863-8. 2001

Collaborators

Detail Information

Publications2

  1. ncbi request reprint Quantifying the interaction between angiotensin-converting enzyme inhibitors and aspirin: are we using the right method?
    M Etminan
    Department of Clinical Epidemiology, University of Toronto, Ontario, Canada
    Pharmacotherapy 21:1247-9. 2001
    ..To assess the interaction between ACE inhibitors and aspirin properly, an additive model-more specifically, the Rothman Synergy Index-should be used. Further investigation with this model, however, is needed...
  2. ncbi request reprint Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials
    M Etminan
    Department of Pharmacy, Baycrest Center for Geriatric Care, Toronto, Ontario, Canada
    Drug Saf 24:863-8. 2001
    ..Recent case reports and letters have alerted practitioners to the risk of sleep attacks, usually preceded by somnolence, in patients with Parkinson's disease treated with pramipexole and ropinirole...